KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome

• Laetitia Furio ,

  Contributed equally to this work with: Laetitia Furio, Georgios Pampalakis

  Affiliations INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Imagine Institute, Paris, France, University Paris Descartes - Sorbonne Paris Cité, Paris, France

  ⨯
• Georgios Pampalakis ,

  Contributed equally to this work with: Laetitia Furio, Georgios Pampalakis

  Affiliation Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Greece

  ⨯
• Iacovos P. Michael,

  Affiliation Samuel Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Andras Nagy,

  Affiliation Samuel Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada

  ⨯
• Georgia Sotiropoulou ,

  * E-mail: gdsotiro@upatras.gr (GS); alain.hovnanian@inserm.fr (AH)

  Affiliation Department of Pharmacy, School of Health Sciences, University of Patras, Rion-Patras, Greece

  ⨯
• Alain Hovnanian

  * E-mail: gdsotiro@upatras.gr (GS); alain.hovnanian@inserm.fr (AH)

  Affiliations INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Imagine Institute, Paris, France, University Paris Descartes - Sorbonne Paris Cité, Paris, France, Department of Genetics, Necker Hospital, Paris, France

  ⨯